Your browser doesn't support javascript.
loading
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Thomas, Jacob S; El-Khoueiry, Anthony B; Maurer, Barry J; Groshen, Susan; Pinski, Jacek K; Cobos, Everardo; Gandara, David R; Lenz, Heinz J; Kang, Min H; Reynolds, C Patrick; Newman, Edward M.
Afiliação
  • Thomas JS; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA. jacob.thomas@med.usc.edu.
  • El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Maurer BJ; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Groshen S; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Pinski JK; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Cobos E; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Gandara DR; Kern Medical Center, Bakersfield, CA, USA.
  • Lenz HJ; Davis Comprehensive Cancer Center, University of California, Sacramento, CA, USA.
  • Kang MH; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Reynolds CP; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Newman EM; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Cancer Chemother Pharmacol ; 87(4): 525-532, 2021 04.
Article em En | MEDLINE | ID: mdl-33423090
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenretinida / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenretinida / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article